Mouse lymphomas caused by an intron-splicing donor site deletion of the FasL gene

Cheng-Chun Wang1, Qi Zeng, Le-Ann Hwang

  • 1Institute of Molecular and Cell Biology, 61 Biopolis Drive, Singapore 138673, Singapore.

Insights

A mutation in the FasL gene causes lymphoma in mice by creating non-functional proteins. This study highlights the FasL gene's importance in lymphocyte development and offers a new mouse model for research.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • The Fas Ligand (FasL) pathway is crucial for immune system regulation.
  • Mutations in genes involved in lymphocyte development can lead to lymphoproliferative disorders.

Purpose of the Study:

  • To investigate the genetic basis of a spontaneous lymphoma observed in mice.
  • To elucidate the role of the FasL gene in lymphocyte development and lymphoma pathogenesis.

Main Methods:

  • Genetic analysis to identify the causative mutation.
  • Transcriptional analysis to assess FasL gene function.
  • Phenotypic characterization of lymphoma in mutant mice, including flow cytometry and organ examination.

Main Results:

  • A 5-bp deletion in the FasL gene's splicing donor site was identified as the cause of lymphoma.
  • Aberrant FasL transcripts led to non-functional proteins, irrespective of mouse genetic background.
  • Mutant mice exhibited lymphoma characterized by specific leukocyte expansion (TCR+CD3+B220+CD19-CD4-CD8-), splenomegaly, and thymic hyperplasia.

Conclusions:

  • The splicing donor site of the FasL gene is critical for its proper function.
  • FasL plays a significant role in normal lymphocyte development.
  • The identified mutant mice provide a valuable model for studying FasL function and related diseases.

Related Concept Videos